Clinical
RSSArticles
-
New PPI Mortality Data: Is There a Risk?
Are proton pump inhibitors associated with excess risk of mortality? That is the finding of a highly publicized study.
-
The Potential Long-term Payoff of Good Initial Diabetes Control
The results of a recent study encourage clinicians to pursue the best control of type 2 diabetes they can attain without incurring significant adverse events.
-
Dietary Omega-3 Fatty Acids Inversely Associated with Diabetic Retinopathy
It remains to be determined whether this isolated ingredient from fish, when taken as a single-entity intervention, will provide similar benefits.
-
The Best BP for High-risk Hypertension Patients
The debate continues.
-
Identification of Pneumococcal Pneumonia
There is no reason to consider urine antigen testing as indicative of less pneumonia lethality.
-
Rheumatoid Arthritis Disease Activity and Calprotectin Levels
Calprotectin may provide a metric for confirmation of optimized control of rheumatoid arthritis, providing additional insight into disease activity beyond clinical symptoms alone.
-
Minimizing Risk of NSAID-associated Recurrent Gastrointestinal Bleeding
Persons who have experienced an NSAID-related upper gastrointestinal bleed would be better served by taking celecoxib than naproxen if continuation of NSAID treatment is required.
-
Is This a Typical Flutter?
Atrial flutter is characterized by a special pattern of regular atrial activity that in adults almost always occurs at a rate of 300/minute (250-350/minute range).
-
Clinical Briefs
In this section: the evolution of prostate cancer screening; the limitations of online health information; and treating polycystic ovary syndrome patients.
-
Valbenazine Capsules (Ingrezza)
Valbenazine is indicated for the treatment of tardive dyskinesia in adults.